Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland-Reference-Cited by-同舟云学术

Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland

Published:2002-03 Issue:3 Volume:52 Page:664-673
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Merrick Gregory S,Butler Wayne M,Galbreath Robert W,Lief Jonathan H,Adamovich Edward

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference38 articles.

1. Combination of prostate specific antigen, clinical stage, and Gleason score to predict pathologic stage of localized prostate cancer;Partin;JAMA,1997

2. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer;Kattan;J Nat Cancer Inst,1998

3. Equivalent biochemical failure free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of >4–20 ng/mL;D’Amico;Int J Radiat Oncol Biol Phys,1997

4. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer;D’Amico;J Clin Oncol,2000

5. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy;Sebo;J Urol,2000

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognosis of patients with prostate cancer receiving permanent seed implantation stratified by prostate volume: Should we be reluctant to treat with brachytherapy because of a very small prostate (<15 cc)?;Radiotherapy and Oncology;2023-11

2. ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer;American Journal of Clinical Oncology;2022-05-06

3. Tumor burden and location as prognostic factors in patients treated by iodine seed implant brachytherapy for localized prostate cancers;Radiation Oncology;2019-12-31

4. Long-term biochemical progression-free survival following brachytherapy for prostate cancer: Further insight into the role of short-term androgen deprivation and intermediate risk group subclassification;PLOS ONE;2019-04-19

5. The American College of Radiology and the American Brachytherapy Society practice parameter for transperineal permanent brachytherapy of prostate cancer;Brachytherapy;2017-01